Atra stock forecast.

Oncology Pharma's stock was trading at $0.3386 at the beginning of the year. Since then, ONPH shares have decreased by 99.9% and is now trading at $0.0002. View the best growth stocks for 2023 here.The average Li Cycle Holdings stock price prediction forecasts a potential upside of 484.05% from the current LICY share price of $0.70. What is LICY's forecast return on equity (ROE) for 2023-2025? (NYSE: LICY) forecast ROE is …Find the latest dividend history for Atara Biotherapeutics, Inc. Common Stock (ATRA) at Nasdaq.com.Euro To Dollar And Dollar To Euro Forecast 2023, 2024-2026. Brent oil price forecast for May 2024. In the beginning price at 70.62 Dollars. High price 72.77, low 70.61. The average for the month 71.42. The Oil Price forecast at the end of the month 71.69, change for May 1.5%. Oil Price forecast for June 2024.Canoo Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 0.33. Negative dynamics for Canoo shares will prevail with possible volatility of 5.391%. Pessimistic target level: 0.32. Optimistic target level: 0.34.

LIT Signals & Forecast. There are mixed signals in the ETF today. The GLOBAL X LITHIUM GLOBAL X LITHIUM ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term …

15 brokers have issued 1-year price targets for Palantir Technologies' stock. Their PLTR share price targets range from $5.00 to $25.00. On average, they anticipate the company's stock price to reach $13.25 in the next year. This suggests that the stock has a possible downside of 34.6%.

The average Atara Biotherapeutics stock price prediction forecasts a potential upside of 1,854.55% from the current ATRA share price of $0.57. What is ATRA's forecast return on equity (ROE) for 2023-2026? Neos Therapeutics, Inc. (NASDAQ:NEOS) posted its quarterly earnings results on Monday, November, 9th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.05. The firm earned $12.54 million during the quarter.Atara Biotherapeutics stock price predictions for 2023, 2024, 2025, 2026, 2027 using artificial intelligence. How much will Atara Biotherapeutics cost in 2021-2025?THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its …The current average ATRA price target, as estimated by these analysts, is $3.00. The predictions for the future ATRA stock price range from a low of $3.00 to a high of $3.00, highlighting the variability of market expectations for ATRA.

According to analyst projections, ATRA’s forecast low is $0.50 with $28.00 as the target high. To hit the forecast high, the stock’s price needs a -5500.0% plunge from its current level, while the stock would need to tank 0.0% for it to hit the projected low. Atara Biotherapeutics Inc (ATRA) estimates and forecasts

Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.

7 equities research analysts have issued 12-month price targets for Luminar Technologies' stock. Their LAZR share price targets range from $3.00 to $20.00. On average, they expect the company's stock price to reach $11.71 in the next twelve months. This suggests a possible upside of 376.2% from the stock's current price.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...The average Atara Biotherapeutics stock price prediction forecasts a potential upside of 1,854.55% from the current ATRA share price of $0.57. What is ATRA's forecast return on equity (ROE) for 2023-2026? Should You Buy or Sell Atara Biotherapeutics Stock? Get The Latest ATRA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.15 brokers have issued 1-year price targets for Palantir Technologies' stock. Their PLTR share price targets range from $5.00 to $25.00. On average, they anticipate the company's stock price to reach $13.25 in the next year. This suggests that the stock has a possible downside of 34.6%.THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl... 4 days ago - Business Wire Atara Biotherapeutics To Participate at the Stifel Healthcare Conference

Plug Power Stock Forecast 2030-2034. In this period, the Plug Power price would rise from $19.25 to $24.13, which is +25%. Plug Power will start 2030 at $19.25, then soar to $19.65 within the first half of the year, and finish 2030 at $20.06. It is about +402% from today. Plug Power Stock Price Forecast 2023-2024.The average Tempest Therapeutics stock price prediction forecasts a potential upside of 1,156.68% from the current TPST share price of $3.74. What is TPST's forecast return on equity (ROE) for 2023-2026? (NASDAQ: TPST) forecast ROE is N/A, which is …TMC the metals company Inc. (TMC) Stock Forecast & Price Target18 brokerages have issued 1-year price objectives for ChargePoint's shares. Their CHPT share price targets range from $2.00 to $17.00. On average, they expect the company's share price to reach $9.13 in the next year. This suggests a possible upside of 380.1% from the stock's current price.Vroom, Inc. (NASDAQ:VRM) posted its earnings results on Tuesday, November, 7th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.18. The company earned $235.63 million during the quarter, compared to analyst estimates of $223.90 million.

Atara Biotherapeutics Stock Price, News & Analysis (NASDAQ:ATRA) $0.65 -0.01 (-1.52%) (As of 12/1/2023 ET) Compare …

Oct 27, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Nov 15, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Atara Biotherapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Atara Biotherapeutics analysts is $ 4.14 . Today 200 Day Moving Average is the resistance level ( 2.216 $).hace 6 días ... The trading price of Atara Biotherapeutics Inc (NASDAQ:ATRA) closed lower on Monday, November 27, closing at $0.63, -3.22% lower than its ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.ATRA | Atara Biotherapeutics, Inc. Healthcare NASDAQ 📈 Technical Chart Patterns & Trend Analysis 📉 Identifying potential trading opportunities based on trend analysis: bullish divergence can be seen oh daily time frame and aslo a double bottom indicating a trend reversal. BUY STOP will be good option in this scenario . 📊 Technical analysis helps id 📈 …Stock Price Forecast The 9 analysts offering 12-month price forecasts for Science Applications International Corp have a median target of 115.00, with a high estimate of 130.00 and a low estimate ... ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock?

Industry. Packaged Software. No executives to display. Corporate headquarters. Ventura, California. Find real-time TTD - Trade Desk Inc stock quotes, company profile, news and forecasts from CNN ...

According to the issued ratings of 4 analysts in the last year, the consensus rating for Atara Biotherapeutics stock is Hold based on the current 3 hold ratings and 1 buy rating for ATRA. The average twelve-month price prediction for Atara Biotherapeutics is $28.00 with a high price target of $31.00 and a low price target of $25.00.

19 equities research analysts have issued 1 year target prices for Paramount Global's stock. Their PARA share price targets range from $9.00 to $30.00. On average, they predict the company's stock price to reach $15.72 in the next twelve months. This suggests that the stock has a possible downside of 0.4%.Facebook Stock Forecast 2023, 2024, 2025. Tesla stock predictions for December 2024. The forecast for beginning of December 330. Maximum value 365, while minimum 323. Averaged Tesla stock price for month 341. Price at the end 344, change for December 4.24%.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.LIT Signals & Forecast. There are mixed signals in the ETF today. The GLOBAL X LITHIUM GLOBAL X LITHIUM ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term …Orchid Island Capital (NYSE:ORC) pays an annual dividend of $1.44 per share and currently has a dividend yield of 19.54%. ORC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ORC.Unlock tomorrow's (ATRA) stock trends with our detailed analysis. Get insights on Atara Biotherapeutics, Inc.'s performance, backed by data-driven predictions for informed investment.Nov 7, 2023 · Analyst projections state that ATRA is forecast to be at a low of $1.40 and a high of $31.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2248.48% from its current level, while the stock would need to crash -6.06% from its current level to reach the projected low. The OptiNose Inc. stock price gained 1.63% on the last trading day (Wednesday, 29th Nov 2023), rising from $1.23 to $1.25. During the last trading day the stock fluctuated 4.02% from a day low at $1.21 to a day high of $1.26. The price has risen in 6 of the last 10 days.This should extend its cash runway past the third quarter of 2025. ATRA stock is down 50.4% as of Thursday morning with some 3.1 million shares traded. For comparison, its daily average trading ...Stock Price Forecast. The 2 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 14.30, with a high estimate of 21.00 and a low estimate of 7.60. The median ...

Nov 23, 2023 · High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year. With the interplay of data, predictions, and real-time performance, Atara Biotherapeutics's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.Spacecraft engine manufacturer and small rocket builder Astra plans to conduct a reverse stock split at a 1 to 15 ratio. Astra also seeks to raise up to $65 million through an "at the market ...The average Bionano Genomics stock price prediction forecasts a potential upside of 532.91% from the current BNGO share price of $1.58. What is BNGO's forecast return on assets (ROA) for 2023-2026? (NASDAQ: BNGO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.13%.Instagram:https://instagram. is amazon stock going to go upbest checking accounts in tennesseesmall cap 600cheap motorcycle insurance az ATRA Stock 12 Months Forecast. $5.05. (890.20% Upside) Based on 8 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. …The FuelCell stock price gained 3.31% on the last trading day (Wednesday, 29th Nov 2023), rising from $1.21 to $1.25.During the last trading day the stock fluctuated 7.88% from a day low at $1.21 to a day high of $1.30.The price has risen in 5 of the last 10 days and is up by 0.81% over the past 2 weeks. Volume fell on the last day by -79 … kikofwhat is the best website for day trading Find real-time ALDX - Aldeyra Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. best banks in vermont 25 Wall Street analysts have issued 1 year price objectives for Pioneer Natural Resources' stock. Their PXD share price targets range from $236.00 to $332.00. On average, they anticipate the company's share price to reach $258.45 in the next twelve months. This suggests a possible upside of 11.3% from the stock's current price.2.46%. $74.52M. Immunogen Inc. 6.11%. $4.3B. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Atara Biotherapeutics (NasdaqGS:ATRA) Stock Forecast & Analyst Predictions - Simply Wall St View Valuation Atara Biotherapeutics Future Growth Future …